Antibiotic developers in the green on Paratek news

|By:, SA News Editor

Stoked by the FDA nod for Paratek Pharmaceuticals' (PRTK +7.4%) NUZYRA (omadacycline), investors are spreading the love to certain other antibiotic makers.

Selected tickers: (AKAO +7.9%)(TTPH +4.2%)(NBRV +5.5%)(MLNT +2.1%)(SPRO +3.1%)(ETTX -3.9%)(ITRM -0.8%)(MRK +0.4%)(MTFB)(SMMT)(OTCQB:IPIX +6.4%)

Previously: Paratek announces FDA approval of NUZYRA (Oct. 3)

Subscribe for full text news in your inbox